Plenful, an AI workflow automation platform streamlining pharmacy and healthcare operations, has announced a $17M Series A round, increasing its total raised capital to more than $25 million. This milestone signifies a meaningful step forward in Plenful's mission to modernize pharmacy operations through advanced automation and artificial intelligence.

The Series A funding round was led by TQ Ventures, with participation from Bessemer Venture Partners, Mitchell Rales (Co-founder and Chairman of Danaher), Susa Ventures, and existing investors.

Plenful is a leading healthcare technology startup dedicated to transforming pharmacy and healthcare operations through advanced workflow automation and AI. Built by healthcare operators and technologists, the company is committed to empowering pharmacies with innovative solutions that enhance efficiency, compliance, and revenue growth.